Home › Funds › Millennium Management › BNTC
Millennium Management position in BNTC
BENITEC BIOPHARMA INC · Health Care
Latest position (Q2 2026)921.30K sh
Reported value held$12.33M
Portfolio Weight0.00%
First reportedQ2 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 25.13K | $29.00K | New |
| Q3 2022 | 52.19K | $19.00K | Add |
| Q1 2025 | 32.05K | $416.92K | New |
| Q4 2025 | 613.16K | $8.26M | New |
| Q1 2026 | 652.06K | $6.94M | Add |
| Q2 2026 | 921.30K | $12.33M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BNTC
- Franklin Resources 2.41M sh · $32.28M · Q2 2026
- Janus Henderson Group 2.88M sh · $30.72M · Q1 2026
- BlackRock Inc 1.41M sh · $18.83M · Q2 2026
- Vanguard Group 1.17M sh · $15.82M · Q4 2025
- Balyasny Asset Management 650.50K sh · $8.70M · Q2 2026
- Geode Capital Management 611.74K sh · $8.19M · Q2 2026
- Northern Trust Corp 178.43K sh · $2.39M · Q2 2026
- Goldman Sachs Group 178.04K sh · $2.38M · Q2 2026
- UBS Group AG 125.43K sh · $1.68M · Q2 2026
- Citadel Advisors 81.47K sh · $1.09M · Q2 2026
- Charles Schwab Investment Management 70.85K sh · $947.99K · Q2 2026